Cost-Effectiveness of Recombinant Activated Factor VII as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients in Germany

Faculty Opinions recommendation of Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1064850.517786 ◽

2007 ◽

Author(s):

Louis Aledort

Keyword(s):

Clinical Trials ◽

Adjunctive Therapy ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Trauma Patients ◽

Severely Injured ◽

Bleeding Control ◽

Double Blind

CE3 SHORT-TERM COST-EFFECTIVENESS OF RECOMBINANT ACTIVATED FACTOR VII IN THE TREATMENT OF INTRACEREBRAL HEMORRHAGE

Value in Health ◽

10.1016/s1098-3015(10)64337-9 ◽

2006 ◽

Vol 9 (3) ◽

pp. A8

Author(s):

SR Earnshaw ◽

MR Wilson ◽

AV Joshi

Keyword(s):

Cost Effectiveness ◽

Intracerebral Hemorrhage ◽

Factor Vii ◽

Short Term ◽

Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-Blind Clinical Trials

Yearbook of Surgery ◽

10.1016/s0090-3671(08)70325-2 ◽

2006 ◽

Vol 2006 ◽

pp. 35-36 ◽

Cited By ~ 1

Author(s):

D.W. Mozingo

Keyword(s):

Clinical Trials ◽

Adjunctive Therapy ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Trauma Patients ◽

Severely Injured ◽

Bleeding Control ◽

Double Blind

1: Recombinant Activated Factor VII (rFVIIa) Upon Arrival in the Emergency Department in the Severely Injured Trauma Patient

Annals of Emergency Medicine ◽

10.1016/j.annemergmed.2007.06.029 ◽

2007 ◽

Vol 50 (3) ◽

pp. S1

Author(s):

S.G. Mehta ◽

E.D. Cox ◽

J.G. Perkins ◽

C.E. Wade ◽

D.F. McLaughlin ◽

...

Keyword(s):

Emergency Department ◽

Trauma Patient ◽

Factor Vii ◽

Severely Injured ◽

Recombinant activated Factor VII in major surgery and trauma patients: a response

Expert Opinion on Drug Safety ◽

10.1517/14740338.4.5.813 ◽

2005 ◽

Vol 4 (5) ◽

pp. 813-814

Author(s):

Randa Grob Zakhary ◽

Stephanie Seremetis

Keyword(s):

Factor Vii ◽

Major Surgery ◽

Trauma Patients ◽

Prediction score for effective bleeding control using recombinant activated factor VII in perioperative nonhemophilic patients

The American Journal of Surgery ◽

10.1016/j.amjsurg.2012.11.016 ◽

2013 ◽

Vol 206 (3) ◽

pp. 326-332 ◽

Cited By ~ 4

Author(s):

Panthila Rujirojindakul ◽

Pairaya Rujirojindakul ◽

Edward B. McNeil ◽

Alan F. Geater ◽

Thavat Chanchayanon ◽

...

Keyword(s):

Prediction Score ◽

Factor Vii ◽

Bleeding Control ◽

Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain

Haemophilia ◽

10.1111/hae.12199 ◽

2013 ◽

Vol 19 (6) ◽

pp. 841-846 ◽

Cited By ~ 9

Author(s):

V. Jimenez-Yuste ◽

R. Núñez ◽

J. A. Romero ◽

B. Montoro ◽

B. Espinós

Keyword(s):

Cost Effectiveness ◽

Prothrombin Complex Concentrate ◽

Factor Vii ◽

Haemophilia A ◽

Severe Haemophilia ◽

Activated Factor Vii ◽

Activated Prothrombin Complex Concentrate ◽

Bleeding Episodes

Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency

General Thoracic and Cardiovascular Surgery ◽

10.1007/s11748-014-0455-1 ◽

2014 ◽

Vol 64 (3) ◽

pp. 177-180 ◽

Cited By ~ 2

Author(s):

Naoko Miyata ◽

Mitsuhiro Isaka ◽

Hideaki Kojima ◽

Tomohiro Maniwa ◽

Shoji Takahashi ◽

...

Keyword(s):

Continuous Infusion ◽

Factor Vii ◽

Bleeding Control ◽

Factor Vii Deficiency ◽

The role of recombinant-activated factor VII in bleeding trauma patients

Current Opinion in Anaesthesiology ◽

10.1097/aco.0b013e32832678c6 ◽

2009 ◽

Vol 22 (2) ◽

pp. 299-304 ◽

Cited By ~ 8

Author(s):

Richard P Dutton ◽

Bianca M Conti

Keyword(s):

Factor Vii ◽

Trauma Patients ◽

Critique of ‘Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial’☆☆Critique of: Richard P. Dutton, Michael Parr, Bartholomew J. Tortella et al. Recombinant Activated Factor VII Safety in Trauma Patients: Results from the CONTROL Trial,The Journal of TRAUMA Injury, Infection, and Critical Care. Volume 71, Number 1, July 2011

Journal of Emergency Medicine Trauma and Acute Care ◽

10.5339/jemtac.2012.18 ◽

2012 ◽

pp. 18

Author(s):

Yassir S. Abdulrahman ◽

Mazin A. Tuma ◽

Husham Abdul Rahman ◽

Ruben Peralta ◽

Rifat Latifi

Keyword(s):

Critical Care ◽

Factor Vii ◽

Trauma Patients ◽

Activated Factor Vii ◽

Trauma Injury